Heron Therapeutics

Company snapshot

Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be inje

• 2 approved product(s) across US/EU regulatory metadata.
• 18 active pipeline program(s) linked via ClinicalTrials.gov.
• 46 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Heron Therapeutics. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Heron Therapeutics.

1. Jun 8, 2026 Clinical update

   SUSTOL — Approved

2. Jun 8, 2026 Clinical update

   GRANISETRON EXTENDED RELEASE INJECTION (GERSC) — Phase 2

3. Jun 8, 2026 Clinical update

   Bupivacaine liposome injectable suspension — Approved

4. Jun 8, 2026 Clinical update

   Bupivacaine Hydrochloride — Approved

5. Jun 8, 2026 Clinical update

   Bupivacaine HCI without epinephrine — Phase 2

View all clinical trial activity →

• What is Heron Therapeutics?

  Heron Therapeutics is a pharma organization headquartered in Cary, USA. It trades on NYSE under ticker HRTX. Primary therapeutic focus areas include Analgesia, Postoperative Pain, Chemotherapy-induced Nausea and Vomiting, Nausea and Vomiting, COVID-19. NovaPharmaNews links 18 cli

• Is Heron Therapeutics publicly traded?

  Yes. Heron Therapeutics is listed with ticker HRTX on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Heron Therapeutics develop or market?

  We link 17 drug profile(s) where Heron Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/heron-therapeutics-inc-de#company-drugs.

• What are the latest developments for Heron Therapeutics?

  In the last 12 months our linked public records show 18 trial program update(s) and 1 US patent grant(s) tied to this profile.

• What therapeutic areas does Heron Therapeutics focus on?

  Heron Therapeutics focuses on Analgesia, Postoperative Pain, Chemotherapy-induced Nausea and Vomiting based on our analysis of their pipeline programs and drug development activities.